Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $59.09 ($1.8M) on 2024-09-10, disclosed to the SEC on 2024-09-12.
Scheduled sale ($1.8M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.09 | 10,000 | $591K | 33.3% |
| 2 | $59.09 | 10,000 | $591K | 33.3% |
| 3 | $59.20 | 10,000 | $592K | 33.4% |
| Total | $59.13 avg | 30,000 | $1.8M | 100% |
| Filing → |
| HALO | SELL | 2026-08-19 | $6.3M | — | Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |